Page 233 - Read Online

Giménez et al. J Cancer Metastasis Treat 2019;5:28 I http://dx.doi.org/10.20517/2394-4722.2018.75 Page 5 of 5

Avalibility of data and materials
Not applicable.

Financial support and sponsorship
None.

Conflicts of interest
The authors declared that there are no conflicts of interest.

Ethical approval and consent to participate
Not applicable.

Consent for publication
Not applicable.

Copyright
© The Author(s) 2019.

REFERENCES
1. Huston T, Pressman P, Moore A. The presentation of contralateral axillary lymph node metastases from breast carcinoma: a clinical
management dilemma. Breast J 2007;13:158-64.
2. Morcos B, Jaradat I, El-Ghanem M, Characteristics of and therapeutic options for contralateral axillary lymph node metastasis in breast
cancer. EJSO 2011;37:418-21.
3. Chkheidze R, Sanders M.A, Haley B. Isolated contralateral axillary lymph node involvement in breast cancer represents a locally
advanced disease not distant metastases. Clin Breast Cancer 2017.
4. Kiluk J, Prowler V, Lee M.C. Contralateral axillary nodal involvement from invasive breast cancer. Breast J 2014;23:291-4.
5. Perre CI, Hoefnagel CA, Kroon BB. Altered lymphatic drainage after lymphadenectomy or radiotherapy of the axilla in patients with
breast cancer. Br. J. Surg 1996;83:1258.
6. van der Ploeg I, Oldenburg H, Rutgers E. Lymphatic drainage patterns from the treated breast. Ann Surg Oncol. 2010;17:1069-75.
7. Allweis T, Parson B, Klein M. Breast cancer draining to bilateral axillary lymph nodes. Surgery 2003;134:506-8.
8. Wang W, Yuan P, Wang J, et al. Management of contralateral axillary lymph node metastasis from breast cancer: a clinical dilemma.
Tumori 2014;100:600-4.
9. Buchanan C, Morris E, Dorn P. Utility of breast magnetic resonance imaging in patients with occult primary breast cancer. Ann Surg
Oncol 2005;12:1045-53.
10. Amin MB, Edge S. AJCC cancer staging manual. 8th ed. Springer; 2017.
11. Moossdorff M, Vugts G, Maaskant-Braat AJ, Strobbe LJ, Voogd AC, et al. Contralateral lymph node recurrence in breast cancer: regional
event rather than distant metastatic disease. A systematic review of the literature. Eur J Surg Oncol 2015;41:1128-36.
12. Cutuli B, Kanoun S, Tunon De Lara C. Breast cancer occurred after Hodgkin’s disease: Clinico-pathological features, treatments and
outcome: analysis of 214 cases. Crit Rev Oncol Hematol 2012;81:29-37.
13. Shaapveld M, Aleman B, van Eggermond A. Second cancer risk up to 40 years after treatment for Hodgkin´s lymphoma. N Engl J Med
2015;373:2499-511.